EAMS scientific opinion: Avalglucosidase alfa in the treatment of Pompe disease
This scientific opinion is issued for avalglucosidase alfa in the treatment of late- and infantile-onset Pompe disease for patients who have already received enzyme replacement therapy with alglucosidase alfa.
Source:
Medicines and Healthcare products Regulatory Agency